サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1771669

米国の医療機器受託製造市場規模、シェア、動向分析レポート：製品別、サービス別、治療分野別、最終用途別、セグメント別予測、2025年～2033年

U.S. Medical Device Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Services, By Therapeutic Area, By End Use, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
米国の医療機器受託製造市場規模、シェア、動向分析レポート：製品別、サービス別、治療分野別、最終用途別、セグメント別予測、2025年～2033年
出版日: 2025年06月20日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の医療機器受託製造市場サマリー

米国の医療機器受託製造市場規模は2024年に167億2,000万米ドルと推計され、2033年には517億6,000万米ドルに達し、2025年から2033年までのCAGRは13.77%で成長すると予測されます。米国の医療機器受託製造部門は、糖尿病、心血管疾患、がんなどの慢性疾患の罹患率の増加、中小規模の相手先ブランド製造業者（OEM）のアウトソーシングの増加、医療技術の複雑化、高度で高品質な機器に対する需要の高まり、コスト効率に対するニーズの高まりなどを背景に、著しい成長を遂げています。

さらに、自動化、3Dプリンティング、スマート製造技術を統合して精度と拡張性を高めることが、市場成長の原動力になると予想されます。さらに、米国の医療機器受託製造における投資や戦略的M&Aの増加は、市場のサービスポートフォリオを拡大し、市場成長にさらに寄与すると予想されます。

また、米国では、相手先ブランド製造業者（OEM）が、業務効率の向上、資本経費の削減、製品上市の迅速化を目的に、さまざまな製造工程のアウトソーシングを行うケースが増えています。これらの企業は、医療機器業界の進化する需要に対応し、標準的な品質で業務を強化するため、CMOへのシフトを強めています。さらに、CMOは医療機器の迅速な市場参入を支援し、生産プロセス内の複数の機能領域を管理することで生産とワークフローの効率を向上させる。その上、医療機器メーカーは生産の一部を外注することにますます重点を置くようになっており、コストを抑えながら内部リソースへのプレッシャーをさらに軽減しています。さらに、CMOと提携することで、機器開発のコストを10～30％削減することができ、さらなる医療機器企業が競争市場で優位に立つために革新的な医療機器を提供できるようになります。

さらに、米国ではFDAによる厳しい規制基準が課されているため、受託製造業者は包括的な品質管理システムを確立する必要があり、世界規模での競争力を高めています。さらに、スマートデバイスやコネクテッドデバイスの需要が高まる中、医療機器受託製造業者は医療モノのインターネットに投資し、サイバーセキュリティ基準の遵守に注力しています。さらに、リショアリングやサプライチェーンの多様化といった動向は、地政学的動向や最近の関税調整を加速させ、市場開拓をさらに後押しすると予想されます。

さらに、医療機器メーカーは、急速な製品開発による競争の激化を目の当たりにする機会が増えており、こうした課題に対処するための受託製造の必要性が高まっています。さらに、低侵襲技術、ウェアラブル技術、診断ツールなどの医療機器の進歩は、規制上の品質保証への注目の高まりと相まって、推定期間中の市場成長を促進すると予想されます。これらの技術革新は、特に低侵襲技術やウェアラブル技術、コンビネーション製品など、機器の製造における精度、拡張性、カスタマイズ性を高める可能性が高いです。このように、米国の医療機器受託製造市場は、技術主導かつイノベーション中心の状況の中で、設計、試作、組立、試験、規制遵守を含む幅広いサービスを提供することで、医療機器企業の進化する要件に対応し、新たな機会を示すことが期待されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の医療機器契約製造市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • テクノロジー情勢
  • 価格モデル分析
  • 米国関税による診断機器契約製造市場への影響分析
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • SWOT分析によるPESTEL
    • COVID-19の影響分析

第4章 米国の医療機器受託製造市場：クラス推定・動向分析

  • 米国の医療機器受託製造市場（クラス別）：セグメントダッシュボード
  • 米国の医療機器受託製造市場（クラス別）：変動分析
  • クラス別、2021年～2033年
  • クラスI
  • クラスII
  • クラスIII

第5章 米国の医療機器受託製造市場：サービス推定・動向分析

  • 米国の医療機器受託製造市場（サービス別）：セグメントダッシュボード
  • 米国の医療機器受託製造市場（サービス別）：変動分析
  • サービス別、2021年～2033年
  • アクセサリー製造
  • 組立製造
  • 部品製造
  • デバイス製造
  • 包装とラベル
  • その他

第6章 米国の医療機器受託製造市場：治療薬分野の推定・動向分析

  • 米国の医療機器受託製造市場（治療分野別）：セグメントダッシュボード
  • 米国の医療機器受託製造市場（治療分野別）：変動分析
  • 治療分野別、2021年～2033年
  • 心臓血管デバイス
  • 整形外科用デバイス
  • 眼科用機器
  • 診断装置
  • 呼吸器系デバイス
  • 手術器具
  • 歯科
  • その他

第7章 米国の医療機器受託製造市場：最終用途の推定・動向分析

  • 米国の医療機器受託製造市場（最終用途別）：セグメントダッシュボード
  • 米国の医療機器受託製造市場（最終用途別）：変動分析
  • 最終用途別、2021年～2033年
  • オリジナル機器メーカー（OEM）
  • 製薬・バイオ医薬品企業
  • その他

第8章 競合情勢

  • 市場参入企業の分類
  • 企業市場シェア/評価分析、2024年
  • 企業プロファイル
    • Jabil Inc.
    • Terumo Corporation
    • WuXi AppTec, Inc.
    • Integer Holdings Corporation
    • Flex Ltd.'s US
    • Sanmina Corporation
    • TE Connectivity
    • Sonic Healthcare
    • Forefront Medical Technology
    • Nortech Systems
    • Phillips-Medisize（a Molex company）
    • Celestica HealthTech
    • Viant Medical

第9章 主な推奨事項

図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Medical Device Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 4 U.S. Medical Device Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Medical Device Contract Manufacturing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 6 U.S. Medical Device Contract Manufacturing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 7 U.S. Medical Device Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 U.S. Medical Device Contract Manufacturing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. Medical Device Contract Manufacturing Market: Product outlook and key takeaways
  • Fig. 20 U.S. Medical Device Contract Manufacturing Market: Product movement analysis
  • Fig. 21 Class I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Class II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Class III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Medical Device Contract Manufacturing Market: Service outlook and key takeaways
  • Fig. 25 U.S. Medical Device Contract Manufacturing Market: Service movement analysis
  • Fig. 26 Accessories Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Assembly Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Component Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Device Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Packaging and Labeling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Medical Device Contract Manufacturing Market: Therapeutic Area outlook and key takeaways
  • Fig. 33 U.S. Medical Device Contract Manufacturing Market: Therapeutic Area movement analysis
  • Fig. 34 Cardiovascular Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Orthopedic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Ophthalmic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Respiratory Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Surgical Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Dental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Medical Device Contract Manufacturing Market: End Use outlook and key takeaways
  • Fig. 43 U.S. Medical Device Contract Manufacturing Market: End Use movement analysis
  • Fig. 44 Original Equipment Manufacturers (OEMs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Service heat map analysis
  • Fig. 48 Strategic framework
目次
Product Code: GVR-4-68040-633-0

U.S. Medical Device Contract Manufacturing Market Summary

The U.S. medical device contract manufacturing market size was estimated at USD 16.72 billion in 2024 and is projected to reach USD 51.76 billion by 2033, growing at a CAGR of 13.77% from 2025 to 2033. The U.S. medical device contract manufacturing sector is witnessing significant growth, fueled by increasing incidence of chronic illnesses such as diabetes, cardiovascular issues, and cancer, rising outsourcing among small to medium sized original equipment manufacturers (OEMs), the growing complexity of medical technologies, rising demand for advanced, high-quality devices and growing need for cost-efficiency.

Moreover, integration of automation, 3D printing, and smart manufacturing technologies to enhance precision and scalability is anticipated to drive the market growth. In addition, rising investments and strategic mergers and acquisitions in U.S. medical device contract manufacturing is expected to expand the market's service portfolios, further contributing to market growth.

In addition, in the U.S. Original Equipment Manufacturers (OEMs) are increasingly outsourcing various production processes to improve operational efficiency, reduce capital expenses, and expedite product launches. These companies are increasingly shifting to CMOs to enhance their operations with standard quality, addressing the evolving demands of the medical device industry. Moreover, CMOs support facilitating faster market entry for medical devices, improving production and workflow efficiencies by managing multiple functional areas within production processes. Besides, medical devices companies are increasingly focusing on outsourcing a portion of their production further reducing the pressure on internal resources while maintaining lower costs. In addition, partnering with CMOs reduces the cost of device development by 10-30%, enabling further medical device companies to deliver innovative medical devices to stay ahead in a competitive market.

Moreover, in the U.S., strict regulatory standards imposed by the FDA necessitate contract manufacturers to establish comprehensive quality control systems, enhancing their competitiveness on a global scale. Moreover, with the increasing demand for smart and connected devices, medical device contract manufacturers are investing in Internet of Medical Things to focus on adhering the cybersecurity standards. In addition, trends such as reshoring and diversifying supply chains are expected to accelerate geopolitical developments and recent tariff adjustments, which further supports market growth.

Furthermore, the medical device manufacturers are increasingly witnessing increasing competition with rapid product development, increasing the need for contract manufacturers to address these challenges. Moreover, advancements in medical devices, such as minimally invasive techniques, wearable technologies, and diagnostic tools, combined with an increased focus on regulatory quality assurance are anticipated to drive the market growth over the estimated time period. These innovations are likely to enhance precision, scalability, and customization in the production of devices, particularly within minimally invasive and wearable technologies, as well as combination products. Thus, the U.S. medical device contract manufacturing market is expected to witness new opportunities within a technology-driven and innovation-centric landscape, addressing the evolving requirements of medical device companies by offering a wide array of services, including design, prototyping, assembly, testing, and regulatory compliance.

U.S. Medical Device Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. medical device contract manufacturing market report based on product, services, therapeutic area, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Class I
  • Class II
  • Class III
  • Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Accessories Manufacturing
  • Assembly Manufacturing
  • Component Manufacturing
  • Device Manufacturing
  • Packaging and Labeling
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular Devices
  • Orthopedic Devices
  • Ophthalmic Devices
  • Diagnostic Devices
  • Respiratory Devices
  • Surgical Instruments
  • Dental
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Original Equipment Manufacturers (OEMs)
  • Pharmaceutical & Biopharmaceutical Companies
  • Others

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Services
    • 1.2.3. Therapeutic Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Value-Chain-Based Sizing & Forecasting
    • 1.7.3. Multivariate Model Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in offshoring medical device manufacturing to the developing economies
      • 3.2.1.2. Rising demand for advanced products
      • 3.2.1.3. Implementation of the international standards by contract manufacturers
      • 3.2.1.4. Rising Price competition and the requirement to reduce cost
      • 3.2.1.5. OEM Focus on Cost Reduction and Core Competency
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance issues while outsourcing
      • 3.2.2.2. Rising labor and operational costs in key markets
      • 3.2.2.3. Contractual obligation
    • 3.2.3. Industry Challenges
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. U.S. Tariffs Impact Analysis on the Diagnostic Device Contract Manufacturing Market
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. U.S. Medical Device Contract Manufacturing Market: Class Estimates & Trend Analysis

  • 4.1. U.S. Medical Device Contract Manufacturing Market, By Class: Segment Dashboard
  • 4.2. U.S. Medical Device Contract Manufacturing Market, By Class: Movement Analysis
  • 4.3. U.S. Medical Device Contract Manufacturing Market Estimates & Forecasts, By Class, 2021 - 2033 (USD Million)
  • 4.4. Class I
    • 4.4.1. Class I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Class II
    • 4.5.1. Class II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Class III
    • 4.6.1. Class III Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Medical Device Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 5.1. U.S. Medical Device Contract Manufacturing Market, By Service: Segment Dashboard
  • 5.2. U.S. Medical Device Contract Manufacturing Market, By Service: Movement Analysis
  • 5.3. U.S. Medical Device Contract Manufacturing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Accessories Manufacturing
    • 5.4.1. Accessories Manufacturing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Assembly Manufacturing
    • 5.5.1. Assembly Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Component Manufacturing
    • 5.6.1. Component Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Device Manufacturing
    • 5.7.1. Device Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Packaging and Labeling
    • 5.8.1. Packaging and Labeling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Medical Device Contract Manufacturing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. U.S. Medical Device Contract Manufacturing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. U.S. Medical Device Contract Manufacturing Market, By Therapeutics Area: Movement Analysis
  • 6.3. U.S. Medical Device Contract Manufacturing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
  • 6.4. Cardiovascular Devices
    • 6.4.1. Cardiovascular Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Orthopedic Devices
    • 6.5.1. Orthopedic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ophthalmic Devices
    • 6.6.1. Ophthalmic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Diagnostic Devices
    • 6.7.1. Diagnostic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Respiratory Devices
    • 6.8.1. Respiratory Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Surgical Instruments
    • 6.9.1. Surgical Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Dental
    • 6.10.1. Dental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Medical Device Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Medical Device Contract Manufacturing Market, By End Use: Segment Dashboard
  • 7.2. U.S. Medical Device Contract Manufacturing Market, By End Use: Movement Analysis
  • 7.3. U.S. Medical Device Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Original Equipment Manufacturers (OEMs)
    • 7.4.1. Original Equipment Manufacturers (OEMs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Pharmaceutical & Biopharmaceutical Companies
    • 7.5.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Jabil Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Terumo Corporation
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. WuXi AppTec, Inc.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Integer Holdings Corporation
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Flex Ltd.'s U.S
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Sanmina Corporation
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. TE Connectivity
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Sonic Healthcare
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Forefront Medical Technology
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Nortech Systems
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Phillips-Medisize (a Molex company)
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Celestica HealthTech
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Viant Medical
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives

Chapter 9. Key Recommendations